Among those questions is whether the effects of sub-concussive hits are identifiable through blood-based molecular information that could unlock new opportunities for innovation and advancement of the game. Researchers at TGen, along with their colleagues, hope to find the answers in the data.
During this phase of the study, TGen faculty and staff have been on the sidelines working closely with their colleagues at Barrow Neurological Institute, A.T. Still University and Desert Testing collecting samples and data.
A baseline sample was collected from all participating players prior to their pre-season workouts. Since then, the researchers have followed the team through their daily workouts and will continue throughout the season, securing samples the day after each practice or game. Through the collection of samples over various points in time and the data generated by Riddell SRS, the goal is to identify the genomic changes in athletes exposed to routine head impacts during practice and games, athletes with diagnosed concussions that recover on both a routine time scale, and athletes with persistent symptoms following concussion that require additional treatment.
"There is no time to waste in bridging the information gathered through Riddell SRS and the genomic information we will gather to hopefully glean a clearer picture of how concussions impact human neurological function in terms of injury, recovery and future risk for long term complications. We are indeed excited to join the ASU football program and Riddell in this pioneering study," said Dr. Jeffrey Trent, TGen President and Research Director.
Following the season long campaign, the researchers will gather post-season baseline data and begin the analysis process with their colleagues at Barrow Neurological Institute and A.T. Still University. During this process, TGen wi
|Contact: Steve Yozwiak|
The Translational Genomics Research Institute